PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)
ANNÉE
2022
AUTEURS
Ducreux M, Desgrippes R, Texier M, Fiore F, Vanelslander P, Capitain O, Guimbaud R, Forestier J, Hajbi F, Follana P, Parzy A, Hamed N, Rinaldi Y, Brotelle T, Pignon JP, Jouffroy C, Dahan L, Bouché O
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES